https://www.selleckchem.com/products/smip34.html
Objective To investigate the use of p16(INK4a) immuno-stained cytology as the primary screening for cervical cancer prevention. Methods From March to August 2018, 902 women from Shenzhen and surrounding area were recruited for cervical cancer screening with ThinPrep Cytologic Test (TCT), cobas4800 HPV test, and p16(INK4a) co-test. Colpo/biopsies were performed using the point of interest biopsy protocol of directed and random cervical biopsies plus endocervical curettage for all women, any of whose tests was positive. Two senior cytopath
Like
Comment
Share
